HR 796
119th Congress
House
Health
Abortion
Consumer affairs
Prescription drugs
Sex and reproductive health
Telephone and wireless communication
Women's health
Second Chance for Moms Act
Introduced: January 28, 2025
Introduced by:
Miller, Mary E.
Republican
· Illinois
See on congress.gov
Everywhere this bill has been
2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jan 28, 2025
Referred to the House Committee on Energy and Commerce.
Jan 28, 2025
Introduced in House
Plain-English summary
Second Chance for Moms Act of 2025
This bill requires labeling of the drug mifepristone to include certain information about the hormone progesterone and establishes a related telephone hotline. (Mifepristone is a drug that is approved to end pregnancies through 10 weeks gestation when used in conjunction with the drug misoprostol. The procedure is often referred to as medication abortion or the abortion pill.)
What's happening now
Referred to the House Committee on Energy and Commerce.
Committees of jurisdiction
1